ViroVet wins “start-up of the year” award

Leuven, Belgium: 17 January 2018 - ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has been presented with the best start-up of the year accolade for the second time. Two years ago, the company was awarded for its concept and ideas, this time the jury bestowed the company for its progress and its ability to raise capital.

More info on the on ViroVet's website.


Next > LindaCare raises € seven million funding to improve remote patient monitoring for chronic disease management

Previous > Avantium’s PEF pilot phase set to be extended